AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm

On June 16, 2026, Allergan Aesthetics, an AbbVie Inc. (NYSE:ABBV) company, announced the U.S. FDA support of Skinvive by Juvederm to trim cervix lines and amended cervix quality successful adults implicit the property of 21. AbbVie said Skinvive by Juvederm is the archetypal and lone hyaluronic acerb injectable indicated to trim the quality of cervix wrinkles and assistance tegument clasp its earthy moisture.

On June 12, 2026, AbbVie Inc. (NYSE:ABBV) announced caller Phase 3 information connected a fixed-duration venetoclax-based operation astatine the European Hematology Association 2026 Congress successful Stockholm, Sweden. Final results from the Phase 3 CLL14 proceedings successful antecedently untreated chronic lymphocytic leukemia showed that venetoclax positive obinutuzumab importantly improved progression-free endurance compared with chlorambucil positive obinutuzumab. The nine-year investigation showed semipermanent off-treatment efficacy and information for the fixed-duration combination, with a median clip to adjacent attraction of 7.6 years.

After a median follow-up of 9.2 years, attraction with venetoclax positive obinutuzumab resulted successful a median progression-free endurance of 6.4 years, compared with 3.2 years for obinutuzumab positive chlorambucil. Last month, AbbVie besides announced that the European Commission authorized an expanded statement for Venclyxto to see usage successful operation with acalabrutinib and with ibrutinib for big patients with antecedently untreated chronic lymphocytic leukemia. The authorization extends to European Union Member States, arsenic good arsenic Iceland, Norway, and Liechtenstein.

AbbVie Inc. (NYSE:ABBV) researches, develops, manufactures, commercializes, and sells medicines and therapies worldwide.

While we admit the imaginable of ABBV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.